New targets for therapy in prostate cancer: modulation of stromal–epithelial interactions
Leland W.K. Chung(VA Palo Alto Health Care System), Haiyen E. Zhau(Cedars-Sinai Medical Center), Thomas A. Gardner(Indiana University), Andrew M. K. Law(Neurology, Inc), Shigeji Matsubara(University of Virginia), Masayuki Egawa(University of Virginia), Chia‐Ling Hsieh(Taipei Medical University Hospital), Shian‐Ying Sung(Taipei Medical University Hospital)
Cited by 55
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520
Insulin-like Growth Factor-I–Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
|Cancer Research|2008|384
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
|The Journal of Urology|2005|363